PREZIOSO, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 941
AS - Asia 844
EU - Europa 268
SA - Sud America 112
AF - Africa 23
OC - Oceania 1
Totale 2.189
Nazione #
US - Stati Uniti d'America 900
SG - Singapore 309
CN - Cina 232
IT - Italia 124
VN - Vietnam 87
BR - Brasile 85
TR - Turchia 78
DE - Germania 34
NL - Olanda 34
CA - Canada 31
PK - Pakistan 31
IN - India 22
BD - Bangladesh 20
HK - Hong Kong 20
FR - Francia 18
GB - Regno Unito 16
ES - Italia 12
FI - Finlandia 10
IL - Israele 10
AR - Argentina 9
PL - Polonia 7
ZA - Sudafrica 7
IQ - Iraq 6
EC - Ecuador 5
MX - Messico 5
CO - Colombia 4
ID - Indonesia 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
RU - Federazione Russa 3
SE - Svezia 3
TN - Tunisia 3
UY - Uruguay 3
AO - Angola 2
CH - Svizzera 2
CL - Cile 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
SA - Arabia Saudita 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
EG - Egitto 1
GY - Guiana 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
SO - Somalia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.189
Città #
San Jose 263
Ashburn 184
Dallas 130
Singapore 95
Rome 73
Santa Clara 59
Beijing 55
San Mateo 39
Kocaeli 34
Ho Chi Minh City 30
Amsterdam 28
Islamabad 28
Chicago 25
Hanoi 21
Toronto 20
Hong Kong 19
Assago 16
Guangzhou 16
Shanghai 15
Brooklyn 14
Frankfurt am Main 14
Los Angeles 12
Shenzhen 11
Chennai 10
Munich 9
New York 9
Netanya 8
São Paulo 8
Montreal 7
Wilmington 7
Boston 6
Helsinki 6
Lawrence 6
Milan 6
Orem 6
Phoenix 6
Princeton 6
West Jordan 6
Baghdad 5
Johannesburg 5
The Dalles 5
Warsaw 5
Brasília 4
Haiphong 4
London 4
Mumbai 4
Quito 4
Thái Bình 4
Tokyo 4
Tân Tiến 4
Xi'an 4
Atlanta 3
Birigui 3
Denver 3
Dhaka 3
Jiaxing 3
San Francisco 3
Stockholm 3
Turku 3
Americana 2
Andalusia 2
Barcelona 2
Barueri 2
Ha Long 2
Kathmandu 2
Lahore 2
Luanda 2
Manchester 2
Montevideo 2
Nairobi 2
Newark 2
Raleigh 2
Recife 2
Rio de Janeiro 2
Salt Lake City 2
Seattle 2
Sfax 2
Thái Nguyên 2
Wuxi 2
Zurich 2
Agawam 1
Alcalá de Guadaira 1
Alexandrov 1
Amman 1
Anaheim 1
Araçatuba 1
Arcos 1
Arlington 1
Armenia 1
Arouca 1
Astolfo Dutra 1
Aubervilliers 1
Avellaneda 1
Baku 1
Bandar Seri Begawan 1
Bandung 1
Beirut 1
Belo Horizonte 1
Benoni 1
Berrechid 1
Totale 1.449
Nome #
Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation 82
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications 78
COS-7-based model: methodological approach to study John Cunningham virus replication cycle 76
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications. 70
SARS-CoV-2: Comparative analysis of different RNA extraction methods 66
Characterization of Human Polyomavirus JC (JCPyV) infection in Human Neuroblastoma SH-SY5Y cells and evaluation of redox state during viral replication 57
Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability Among a HIV-1-Positive Population 57
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients 56
John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy 52
COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains 51
Evaluation of redox state alterations in influenza A virus-infected neuronal cells: involvement in neurotropism. 47
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 47
Stillbirth and fetal capillary infection by SARS-CoV-2 46
Genetic Diversity of the Noncoding Control Region of the Novel Human Polyomaviruses 45
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 45
Detection analysis and study of genomic region variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the urine and plasma of HIV-1-infected patients 44
Role of miR-9 in Modulating NF-κB Signaling and Cytokine Expression in COVID-19 Patients 44
Kidney graft failure induced by BKPyV replication despite a strong reduction of the immunosuppressive therapy 43
JC polyomavirus. A short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence 43
Evaluation of merkel cell polyomavirus DNA in tissue samples from italian patients with diagnosis of MCC 43
Detection of Merkel cell polyomavirus (mcpyv) dna and transcripts in Merkel cell carcinoma (mcc) 43
Identification and Antimicrobial Susceptibility Testing of Microorganisms From Positive blood Cultures by a Combined Lysis-centrifugation Method with MALDI-TOF MS and VITEK2 System 42
Common microbial genital infections and their impact on the innate immune response to HPV in cervical cells 42
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 42
SARS-CoV-2 epidemiological surveillance of healthcare professionals working in an inpatient rehabilitation facility 41
HPyV6 and HPyV7 in urine from immunocompromised patients 40
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma 40
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 40
The effect of Torque Teno Virus (TTV) Infection on Clinical Outcomes, Genomic Integrity, and Mortality in COPD Patients 40
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 38
High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis 37
Detection of Quebec polyomavirus DNA in samples from different patient groups 37
Role of virus-induced host cell epigenetic changes in cancer 37
Correlation between Chest Computed Tomography Score and Laboratory Biomarkers in the Risk Stratification of COVID-19 Patients Admitted to the Emergency Department 37
Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens 37
Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region’s genetic variability 35
Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study 35
Merkel cell polyomavirus and Merkel cell carcinoma 35
BK virus and transplantation 35
COVID-19. Update of the Italian situation 35
Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time 35
Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection 35
Reply to Henriksen, S.; Rinaldo, C.H. Should SVGp12 be used for JC polyomavirus studies? comment on “prezioso et al. COS-7 and SVGp12 cellular models to study JCPyV replication and microRNA expression after infection with archetypal and rearranged-NCCR viral strains. Viruses 2022, 14, 2070 34
Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer 33
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 33
The inhibition of DNA viruses by the amphibian antimicrobial peptide temporin G. A virological study addressing HSV-1 and JPCyV 31
The "Three Italy" of the COVID-19 epidemic and the possible Involvement of SARS-CoV-2 in triggering complications other than pneumonia 30
Regulation of transcriptional activity of Merkel cell polyomavirus large T-Antigen by PKA-mediated phosphorylation 30
Merkel cell polyomavirus DNA detection in respiratory samples: study of a cohort of patients affected by cystic fibrosis 27
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 27
Structural analysis of merkel cell polyomavirus (MCPyV) viral capsid protein 1 (VP1) in HIV-1 infected individuals 25
Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment 24
Multimarker Approach: An Effective Tool in the Risk Stratification of Patients Admitted to the Emergency Department 16
Rhus coriaria Linn Extract as a Natural Inhibitor of Influenza A Virus Replication In Vitro 14
The gut and circulating virome: emerging players in aging and longevity 3
Totale 2.257
Categoria #
all - tutte 19.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202270 0 18 20 1 0 0 12 6 0 12 1 0
2022/202342 19 0 2 2 1 0 0 0 5 11 2 0
2023/2024137 1 0 0 4 7 3 0 38 8 10 17 49
2024/2025489 34 70 48 11 33 49 34 24 84 12 17 73
2025/20261.469 104 122 105 85 113 142 287 100 159 188 32 32
Totale 2.257